digital currency europe- Top Knowledge

Alipay sells cryptocurrency funds? Originally an indirect investment in a product of Huabao Fund, the subscription has been suspended. Recently, some netizens found that Huabao Fund promoted a fund product issued by Huabao Fund in Alipay-QDII-FOF-LOF C (hereinafter referred to as "Huabao Overseas Technology C"), promoting "riding the wind to encrypt the rising market of currency" and "the representative of subversive innovation technology: cryptocurrency". According to the report of Warburg Overseas Technology C in the third quarter of this year, among the top ten funds with the highest fair value at the end of the reporting period, five were only index funds managed by Ark Investment Management under Cathy Wood, the "Mujie", accounting for 73.12% of the total. Looking through the archives of ARK Management Fund, the reporter found that ARK Innvonation ETF (hereinafter referred to as "ARKK"), the largest heavyweight of Huabao Overseas Technology C, was invested in Coinbase, a cryptocurrency exchange. ARK Next Generation Internet ETF (hereinafter referred to as "ARKW"), the second largest warehouse, invests in GBTC(Grayscale Bitcoin Trust) or investment tools such as Bitcoin, Ethereum and other cryptocurrency ETFs. ARKW also suggests the risks related to the indirect investment of funds in cryptocurrencies. In addition, Coinbase ranks third among ARKW's heavy stocks. The reporter logged on to several consignment platforms such as Ant Fortune, Licaitong, Tiantian Fund, China Merchants Bank, Snowball Fund and found that the product was sold on the above platforms, but from December 11th, the large subscription of Class A shares and Class C shares was suspended, and the daily limit for each person was 1000 yuan RMB. However, on December 13th, Huabao Overseas Science and Technology Stock Securities Investment Fund announced that it would suspend subscription and regular fixed investment business. (21 Finance)Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.The closing price of the national carbon market rose by 0.84% compared with the previous day. Today, the comprehensive price of the national carbon market is: the opening price is 99.66 yuan/ton, the highest price is 101.74 yuan/ton, the lowest price is 98.95 yuan/ton, and the closing price is 100.74 yuan/ton, which is 0.84% higher than the previous day. The transaction volume of today's listing agreement is 464,194 tons, with a turnover of 46,118,764.87 yuan; The volume of bulk agreement transactions was 4,617,079 tons, with a turnover of 450,306,945.18 yuan. Today, the total turnover of the national carbon emission quota is 5081273 tons, with a total turnover of 496425710.05 yuan. From January 1 to December 13, 2024, the volume of carbon emission quota in the national carbon market was 169,736,665 tons, with a turnover of 162,864,7748.47 yuan. As of December 13, 2024, the cumulative turnover of carbon emission quotas in the national carbon market was 611,359,276 tons, with a cumulative turnover of 412,056,282,67.75 yuan. (National Carbon Trading)

SINOMACH Seiko: It is planned to invest 73.6 million yuan to build an industrialization project of superhard tool. The company plans to invest in the industrialization project of superhard tool, and the main body of implementation is SINOMACH Diamond (Henan) Co., Ltd., a holding subsidiary of the company holding 67% equity. The total investment of the project is 73.6 million yuan, and the project construction period is about 12 months.Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.

The U.S. House of Representatives passed a bill to expand the judiciary.Market news: South Korean prosecutors approved the postponement of the execution of the ruling request of Cao Guo, the leader of the opposition motherland reform party.Gao Xiuying, the former deputy general manager of CITIC Daika Co., Ltd., was "double-opened". After investigation, Gao Xiuying, as a leading cadre of party member, a state-owned enterprise, abandoned his initial mission and deliberately opposed organizational review, taking the lead in breaking the discipline and breaking the law, seriously polluting the political ecology of his unit; Ignoring the spirit of the eight central regulations, illegally accepting gifts, banquets and travel arrangements; Violation of organizational principles, failure to report personal matters truthfully, running away from official positions, and making profits for relatives and friends in employee recruitment and job transfer; There is no bottom line for honesty, illegally holding shares of non-listed companies, and wantonly engaging in illegal business operations abroad to obtain huge profits; Failing to report and submit working materials to the superior unit as required; Moral corruption, violation of life discipline. Rely on enterprises to eat enterprises, harm the public and enrich the private interests, use their powers to ask for property from subordinates, illegally operate the same business of the enterprises they serve, and seek huge illegal interests.